Glancy Prongay & Murray LLP is investigating Wealthfront Corporation for potential securities law violations after the company reported significant financial setbacks. Wealthfront's stock fell sharply following disclosures of large net deposit outflows and declining gross profit margins, partly due to startup costs from its new home-lending business. The investigation highlights concerns about the company's financial health and management disclosures, urging affected investors to consider legal action. The situation remains fluid as the company navigates these challenges and potential ownership changes in its home-lending segment.
Vishay Intertechnology's shares surged nearly 14% after reporting Q1 revenue of $839.2 million and EPS of $0.05, beating analyst expectations and guiding Q2 revenue above forecasts. This pushed its stock to an all-time high and a 300% year-to-date ra...
Port Alberni, British Columbia, has been selected for the first-ever Home Town Takeover Canada series, set to premiere on HGTV this fall. The show, hosted by Bryan and Sarah Baeumler, will focus on revitalizing the town through home, business, and pu...
Gilead Sciences and Merck have stopped their Phase 3 trial combining Trodelvy and Keytruda for metastatic non-small cell lung cancer after it failed to show statistically significant benefits. However, they announced positive Phase 3 results for a ne...
American Airlines has signed the largest sustainable aviation fuel (SAF) certificate agreement with Google, securing 35 million gallons of SAF over three years to reduce nearly 300,000 metric tons of CO₂ emissions. This deal supports American Airline...
The Treg cell-based therapies pipeline is robust with more than 29 pharmaceutical companies developing over 35 therapies targeting autoimmune diseases, graft-versus-host disease, and transplant rejection. Key players like Orca Bio, Cellenkos, and Que...
